This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
4dn:phase2:working_groups:predictive_modeling_mechanisms [2021/01/07 11:41] oh [TEST TEST] |
4dn:phase2:working_groups:predictive_modeling_mechanisms [2025/04/22 16:21] (current) |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== Predictive Modeling/Models and Mechanisms ====== | ====== Predictive Modeling/Models and Mechanisms ====== | ||
- | **Point people/organizers: //Jian Ma, Katie Pollard, Christina Leslie, Yun Li// ** | + | **Point people/organizers: **//Jian Ma, Katie Pollard, Christina Leslie, Yun Li// |
- | ===== Mission Statement ===== | + | <font inherit/inherit;;#c0392b;;inherit>**4DN Google Drive folder:**</font> [[https://drive.google.com/drive/folders/1Oz_B2nwooMguqO8yKCoKVV2hhxek29C6?usp=sharing|https://drive.google.com/drive/folders/1Oz_B2nwooMguqO8yKCoKVV2hhxek29C6?usp=sharing]] |
- | The overarching goal of this Working Group is to foster collaborations in the 4DN Consortium for the development of predictive models to reveal fundamental molecular mechanisms that connect structure and function of the 4D Nucleome. We expect that this Working Group will coordinate consortium-wide activities related to computational model development for mechanistic understanding of nuclear structure and function, maximize the complementarity of different data modalities from various biological systems, assess the impact of nuclear structure in human health and diseases, and facilitate coordinated outreach in computational development to other NIH Consortia and the broad community. The deliverables from this Working Group will include best practices for the 4DN community, new methods, common datasets, and collaborative publications. Initial discussions from the Working Group will include the following topics. | + | <font inherit/inherit;;#c0392b;;inherit>**4DN Calendar: **</font>[[https://wiki.4dnucleome.org/4dn:calendar_4dn|https://wiki.4dnucleome.org/4dn:calendar_4dn]] ([[https://ics.teamup.com/feed/ksrqw1wb728dtrxdvg/9148079.ics|click here]] to add this specific WG calendar to your personal calendar) |
- | ===== TEST TEST ===== | + | **<font inherit/inherit;;#c0392b;;inherit>Agenda/minutes:</font>** [[https://docs.google.com/document/d/1jLAWlUDayZcxhVWbN2DiDlKulkNLoCJsy93n95swkRY/edit?usp=sharing|https://docs.google.com/document/d/1jLAWlUDayZcxhVWbN2DiDlKulkNLoCJsy93n95swkRY/edit?usp=sharing]] |
- | * Predictive model development and benchmark datasets for mechanistic understanding of the nuclear organization | + | **<font inherit/inherit;;#c0392b;;inherit>Meeting attendee spreadsheet:</font> ** [[https://docs.google.com/spreadsheets/d/18MXxoUPHPNd4yz440NMXx9-feo6zI2C0mlnM40vMjtg/edit?usp=sharing|https://docs.google.com/spreadsheets/d/18MXxoUPHPNd4yz440NMXx9-feo6zI2C0mlnM40vMjtg/edit?usp=sharing]] |
- | * Learning the roles of sequence, epigenomic signatures, RNAs, and trans-factors on nuclear structure features and their formation mechanisms (e.g., loop extrusion, phase separation) | + | |
- | * Learning the context-dependent connections between 3D genome structure (including its dynamics) and vital genome functions (e.g., transcription, DNA replication, DNA repair, recombination, X-inactivation) | + | |
- | * Interpreting the cell type-specific impact of genetic variants on nuclear structure and function, with additional integration with medical genetics datasets in health and diseases | + | |
- | * Assessing the phenotypic impact of 3D genome organization at various levels (i.e., molecular, cellular, and organism) | + | **<font inherit/inherit;;#c0392b;;inherit>Collaboration document:</font> ** [[https://docs.google.com/document/d/1eRQQWrEQJkmPEOp2y2n-QeKKexCB6nHqVBFCsTCgsc0/edit?usp=sharing|https://docs.google.com/document/d/1eRQQWrEQJkmPEOp2y2n-QeKKexCB6nHqVBFCsTCgsc0/edit?usp=sharing]] |
- | * Benchmark loci and datasets for experimental validations | + | <font inherit/inherit;;#c0392b;;inherit>**Email list:**</font> <model-mechanism@4dnucleome.org> |
+ | <font inherit/inherit;;#c0392b;;inherit>**Slack channel:**</font> #wg-predictive-modeling | ||
- | ===== TEST TEST ===== | + | ===== Mission Statement ===== |
- | - Predictive models for multiscale navigable 4D Nucleome maps to reveal nuclear organization mechanisms | + | The overarching goal of this Working Group is to foster collaborations in the 4DN Consortium for the development of predictive models to reveal fundamental molecular mechanisms that connect structure and function of the 4D Nucleome. We expect that this Working Group will coordinate consortium-wide activities related to computational model development for mechanistic understanding of nuclear structure and function, maximize the complementarity of different data modalities from various biological systems, assess the impact of nuclear structure in human health and diseases, and facilitate coordinated outreach in computational development to other NIH Consortia and the broad community. The deliverables from this Working Group will include best practices for the 4DN community, new methods, common datasets, and collaborative publications. Initial discussions from the Working Group will include the following topics. |
- | - Integration of multimodal datasets, including genomic assays and imaging methods | + | * **Predictive model development and benchmark datasets for mechanistic understanding of the nuclear organization** |
- | + | * Learning the roles of sequence, epigenomic signatures, RNAs, and trans-factors on nuclear structure features and their formation mechanisms (e.g., loop extrusion, phase separation) | |
- | - Integration of single-cell 3D genome measurements for mechanistic understanding of cell-to-cell variability | + | * Learning the context-dependent connections between 3D genome structure (including its dynamics) and vital genome functions (e.g., transcription, DNA replication, DNA repair, recombination, X-inactivation) |
- | + | * Interpreting the cell type-specific impact of genetic variants on nuclear structure and function, with additional integration with medical genetics datasets in health and diseases | |
- | Integration of perturbation datasets to uncover causal relationships of structure and function | + | * Assessing the phenotypic impact of 3D genome organization at various levels (i.e., molecular, cellular, and organism) |
- | + | * Benchmark loci and datasets for experimental validations | |
- | Determining the most informative set of data types for various 4DN maps in multiple scales | + | * **Predictive models for multiscale navigable 4D Nucleome maps to reveal nuclear organization mechanisms** |
- | + | * Integration of multimodal datasets, including genomic assays and imaging methods | |
- | Integrative modeling for realistic nuclear structures and dynamics | + | * Integration of single-cell 3D genome measurements for mechanistic understanding of cell-to-cell variability |
- | + | * Integration of perturbation datasets to uncover causal relationships of structure and function | |
- | Best practices for predictive machine learning model development | + | * Determining the most informative set of data types for various 4DN maps in multiple scales |
- | + | * Integrative modeling for realistic nuclear structures and dynamics | |
- | <code> | + | * **Best practices for predictive machine learning model development** |
- | Model selection, formulation, and transferring, e.g. neural network architectures | + | * Model selection, formulation, and transferring , e.g. neural network activities |
- | </code> | + | * Model evaluation strategies to enhance rigor and reproducibility |
- | + | * Model interpretability, generalizability, visualization, and expressiveness to reveal important biological features | |
- | Model evaluation strategies to enhance rigor and reproducibility | + | * **Experimental design from predictive modeling** |
- | + | * Optimizing consortium-wide shared resources by using predictive models to prioritize loci or perturbations that will maximize discovery | |
- | Model interpretability, generalizability, visualization, and expressiveness to reveal important biological features | + | * Predicting missing data sets (e.g., cell types, assays) that, if collected, would enhance prediction accuracy or our ability to derive mechanisms from modeling |
- | + | * Guiding sound experimental design across consortium projects (e.g., for controlling batch effects or maximizing power). | |
- | Experimental design from predictive modeling | + | |
- | + | ||
- | Optimizing consortium-wide shared resources by using predictive models to prioritize loci or perturbations that will maximize discovery | + | |
- | + | ||
- | Predicting missing data sets (e.g., cell types, assays) that, if collected, would enhance prediction accuracy or our ability to derive mechanisms from modeling | + | |
- | + | ||
- | Guiding sound experimental design across consortium projects (e.g., for controlling batch effects or maximizing power). | + | |